Medical Use of Byproduct Material-Medical Event Definitions, Training and Experience, and Clarifying Amendments
Nuclear Regulatory Commission · 2018
Read Medical Use of Byproduct Material-Medical Event Definitions, Training and Experience, and Clarifying Amendments by Nuclear Regulatory Commission (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/uslaw-fr-2018-14852.txt.
Description
Rule published in the Federal Register on 2018-07-16 by Nuclear Regulatory Commission. Text from federalregister.gov (official edition: govinfo). [Pages 33046-33112] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2018-14852] [[Page 33045]] Vol. 83 Monday, No. 136 July 16, 2018 Part IV Nuclear Regulatory Commission ----------------------------------------------------------------------- 10 CFR Parts 30, 32, and 35 Medical Use of Byproduct Material--Medical Event Definitions, Training and Experience, and Clarifying Amendments; Final.
Catalog record
| CREATOR | Nuclear Regulatory Commission |
|---|---|
| YEAR | 2018 |
| COLLECTION | LAW |
| FORMAT | TXT |
| FILE SIZE | 543 KB |
| VERSION | 1.0 |
| LICENSE | Public Domain |
| RIGHTS | PUBLIC DOMAIN |
| SOURCE | Federal Register |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Medical Use of Byproduct Material-Medical Event Definitions, Training and Experience, and Clarifying Amendments Citation: us:fr:2018-14852 Creator: Nuclear Regulatory Commission Year: 2018 Source-URL: https://www.federalregister.gov/documents/2018/07/16/2018-14852/medical-use-of-byproduct-material-medical-event-definitions-training-and-experience-and-clarifying Context: Rule published in the Federal Register on 2018-07-16 by Nuclear Regulatory Commission. Text from federalregister.gov (official edition: govinfo). [Pages 33046-33112] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2018-14852] [[Page 33045]] Vol. 83 Monday, No. 136 July 16, 2018 Part IV Nuclear Regulatory Commission ----------------------------------------------------------------------- 10 CFR Parts 30, 32, and 35 Medical Use of Byproduct Material--Medical Event Definitions, Training and Experience, and Clarifying Amendments; Final Rules Federal Register / Vol. 83 , No. 136 / Monday, July 16, 2018 / Rules and Regulations [[Page 33046]] ----------------------------------------------------------------------- NUCLEAR REGULATORY COMMISSION 10 CFR Parts 30, 32, and 35 [NRC-2008-0175] RIN 3150-AI63 Medical Use of Byproduct Material--Medical Event Definitions, Training and Experience, and Clarifying Amendments AGENCY: Nuclear Regulatory Commission. ACTION: Final rule. ----------------------------------------------------------------------- SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is amending its regulations related to the medical use of byproduct material. The final rule will amend the NRC regulations related to the medical use of byproduct material. This rule amends the reporting and notification requirements for a medical event (ME) for permanent implant brachytherapy. This rule also amends the training and experience (T&E) requirements to remove from multiple sections the requirement to obtain a written attestation for an individual who is certified by a specialty board whose certification process has been recognized by the NRC or an Agreement State; and address a request filed in a petition for rulemaking (PRM), PRM-35-20, to exempt certain board-certified individuals from certain T&E requirements (i.e., ``grandfather'' these individuals). Additionally, this rule amends the requirements for measuring molybdenum contamination; adds a new requirement for the reporting of failed technetium and rubidium generators; and allows licensees to name associate radiation safety officers (ARSOs) on a medical license. DATES: This final rule is effective on January 14, 2019. ADDRESSES: Please refer to Docket ID NRC-2008-0175 when contacting the NRC about the availability of information for this action. You may obtain publicly-available information related to this action by any of the following methods: Federal Rulemaking Website: Go to http://www.regulations.gov and search for Docket ID NRC-2008-0175. Address questions about NRC dockets to Carol Gallagher; telephone: 301-415- 3463; email: [email protected]. For technical questions, contact the individual listed in the FOR FURTHER INFORMATION CONTACT section of this document. NRC's Agencywide Documents Access and Management System (ADAMS): You may obtain publicly-available documents online in the ADAMS Public Documents collection at http://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``ADAMS Public Documents'' and then select ``Begin Web-based ADAMS Search.'' For problems with ADAMS, please contact the NRC's Public Document Room (PDR) reference staff at 1-800-397-4209, 301-415-4737, or by email to [email protected]. For the convenience of the reader, instructions about obtaining materials referenced in this document are provided in the ``Availability of Documents'' section. NRC's PDR: You may examine and purchase copies of public documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. FOR FURTHER INFORMATION CONTACT: Kimyata Morgan-Butler, Office of Nuclear Material Safety and Safeguards, U.S. Nuclear Regulatory Commission, Washington, DC 20555-0001, telephone: 301-415-0733, email: [email protected]. SUPPLEMENTARY INFORMATION: Executive Summary A. Need for the Regulatory Action and Legal Authority The NRC is amending its regulations related to the medical use of byproduct material. These regulations were last amended in their entirety in 2002. Over the last 14 years, stakeholders and members of the medical community have identified certain issues in implementing these regulations. As a result, the NRC is updating its regulations to address technological advances and changes in medical procedures. The amended rule would also enhance patient safety. The NRC is revising parts 30, 32, and 35 of title 10 of the Code of Federal Regulations (10 CFR) under the legal authority granted to the NRC by the Atomic Energy Act of 1954, as amended, and the Energy Reorganization Act of 1974, as amended. B. Major Provisions The final rule establishes separate requirements for identifying and reporting MEs involving permanent implant brachytherapy. These new regulations require reporting of an event in which there is actual or potential harm to a patient resulting from an ME. Additionally, licensees are required to develop, implement, and maintain procedures for determining if an ME has occurred, including procedures for verifying certain aspects of a permanent implant brachytherapy treatment within 60 days from the date the treatment was performed. Note that the terms ``ME,'' ``ME definition,'' ``ME criteria,'' and ``ME reporting criteria'' are used interchangeably in the Executive Summary and the Discussion sections of this document. Training and experience requirements are amended in multiple sections to remove the requirement to obtain a written attestation for an individual who is certified by a specialty board whose certification process has been recognized by the NRC or an Agreement State. The NRC has determined that certification by a specialty board, coupled with meeting the recentness of training requirements, is sufficient to demonstrate that an individual seeking authorization on a license has met the T&E requirements and has the requisite current knowledge and, therefore, additional attestation by a preceptor is unnecessary. Individuals who are not board certified will still need to obtain a written attestation; however, the language of the attestation is modified. Additionally, residency program directors will be allowed to provide these written attestations. Note that the terms ``written attestation,'' ``attestation,'' ``preceptor statement,'' and ``preceptor attestation'' are used interchangeably in the Executive Summary and the Discussion sections of this document. The rule addresses the issues raised in a petition for rulemaking (PRM-35-20) that was submitted to the NRC in 2006. The petition requested that experienced board-certified Radiation Safety Officers (RSOs) and medical physicists not named on a license who had practiced certain modalities prior to October 24, 2005, be exempt from the specific T&E requirements in Sec. Sec. 35.50 and 35.51, respectively. In effect, they will be ``grandfathered'' for these training requirements for the modalities that they practiced as of October 24, 2005. This petition is discussed in detail in Section II., Petition for Rulemaking, PRM-35-20, of this document. The requirements for measuring the molybdenum-99 (Mo-99) concentration for elutions of Mo-99/Technetium-99m (Tc-99m) generators are changed and requirements are added for reporting and notification of a generator eluate exceeding permissible Mo-99, strontium-82 (Sr- 82), or strontium-85 (Sr-85) concentrations. The occurrence of generator eluate exceeding permissible concentrations is also referred to as ``breakthrough.'' The current requirement to measure the Mo-99 concentration after the first eluate is changed to require that the Mo- 99 concentration be measured in each eluate. This requirement is changed in [[Page 33047]] response to several breakthrough incidents reported to the NRC. Additionally, licensees will be allowed to appoint a qualified individual with expertise in certain uses of byproduct material to be named on a license to serve as an ARSO. This will make it easier for an individual to become an RSO on other medical licenses and will increase the number of individuals who are available to serve as preceptors for individuals seeking to be appointed as RSOs or ARSOs. C. Costs and Benefits The NRC has not established a quantitative cutoff for defining an economically significant regulatory action for